Issue 2 2022最新文献

筛选
英文 中文
Metabolic cardiocytoprotectors (trimetazidine and trimethylhydrazine) in geriatrics.Short review 代谢性心肌细胞保护剂(曲美他嗪和三甲肼)在老年病学中的应用。短的审查
Issue 2 2022 Pub Date : 2022-06-07 DOI: 10.47855/jal9020-2022-2-5
L. Kuprash, O. Kuprash, Svetlana Gudarenko
{"title":"Metabolic cardiocytoprotectors (trimetazidine and trimethylhydrazine) in geriatrics.\u0000Short review","authors":"L. Kuprash, O. Kuprash, Svetlana Gudarenko","doi":"10.47855/jal9020-2022-2-5","DOIUrl":"https://doi.org/10.47855/jal9020-2022-2-5","url":null,"abstract":"The review presents the clinical studies results of the effectiveness of cardiocytoprotectors, fatty acids synthesis inhibitors, trimetazidine (preductal), and trimethylhydrazine (meldonium, mildronate) in the treatment of cardiovascular disease (angina pectoris, chronic heart failure) and the central nervous system disease (dyscirculatory encephalopathy, chronic cerebral insufficiency, stroke) various ages patients. These data indicate the prospects of using these drugs in the complex therapy of cardiovascular and cerebrovascular diseases in the geriatric clinic. Keywords: metabolic cardiocytoprotectors, cardiovascular and cerebrovascular pathology, trimethylhydrazine, elderly","PeriodicalId":395284,"journal":{"name":"Issue 2 2022","volume":"145 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-06-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114779393","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Structural damage of myelin in experimental Parkinsonism and prospects for their drug correction in the clinic of Parkinson's disease 实验性帕金森病髓磷脂结构损伤及其在帕金森病临床药物矫正的前景
Issue 2 2022 Pub Date : 2022-05-09 DOI: 10.47855/jal9020-2022-2-3
K. Rozova, Tatiana Gasyuk, N. Karasevich, I. Karaban
{"title":"Structural damage of myelin in experimental Parkinsonism and prospects for their drug correction in the clinic of Parkinson's disease","authors":"K. Rozova, Tatiana Gasyuk, N. Karasevich, I. Karaban","doi":"10.47855/jal9020-2022-2-3","DOIUrl":"https://doi.org/10.47855/jal9020-2022-2-3","url":null,"abstract":"Changes in myelin ultrastructure under experimental Parkinsonism in the tissues of the medulla oblongata and striatum were performed under experimental Parkinsonism induced by rotenone administration in 30 adult rats of the Wistar line. Clinico-electromyographic studies were performed on patients with Parkinson's disease with a stage of disease 2.0 -3.0 (Hoehn a. Yahr). \u0000Efficacy of Cerebrolysin has been shown to correct myelin abnormalities to elucidate the effect on the muscle reflex response to irritation of sensitive nerve fibres of the mixed nerve with subsequent monosynaptic activation of motor neurons and spinal cord neurons. One of the mechanisms associated with myelin damage in Parkinsonism is the development of mitochondrial dysfunction, in any case, its ultrastructural component. The use of Cerebrolysin leads to a significant elimination of mitochondrial dysfunction and myelin damage. It can be assumed that the positive effect of the drug lies in the antioxidant effect, which, in turn, effect the transmembrane conductivity, which should be considered one of the neuroprotective effects of the drug.\u0000\u0000Keywords: experimental Parkinsonism; Parkinson's disease; myelin; medulla oblongata; sriatum; mitochondrial dysfunction; transmembrane conductivity; cerebrolysin.","PeriodicalId":395284,"journal":{"name":"Issue 2 2022","volume":"20 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-05-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"133643996","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Estimating the functional age of the cardiorespiratory system 估计心肺系统的功能年龄
Issue 2 2022 Pub Date : 2022-05-04 DOI: 10.47855/jal9020-2022-2-2
A. Pisaruk, V. Shatilo, I. Antoniuk-Shcheglova, V.Р. Chyzhova, L. Mekhova, S. Naskalova, N. Koshel, S. Ivanov
{"title":"Estimating the functional age of the cardiorespiratory system","authors":"A. Pisaruk, V. Shatilo, I. Antoniuk-Shcheglova, V.Р. Chyzhova, L. Mekhova, S. Naskalova, N. Koshel, S. Ivanov","doi":"10.47855/jal9020-2022-2-2","DOIUrl":"https://doi.org/10.47855/jal9020-2022-2-2","url":null,"abstract":"Based on our data on age-related changes in indicators of blood pressure, ECG, HRV, capillaroscopy, and spirography developed a methodology for assessing the biological (functional) age cardiorespiratory system. The study included 116 apparently healthy people aged 20 to 90 years. The formula for calculating functional age was obtained by stepwise multiple regression. Multiple correlation between predicted age and chronological age is large (r = 0.891; p< 0.00001). The mean absolute value of the BA calculation error, in this case, is 6.12 ± 4.36 years.\u0000The method developed by us for assessing the functional age of the cardiorespiratory system has sufficiently high accuracy and can be used to assess the risk of developing an age-dependent pathology of the cardiorespiratory system. The implementation of the proposed method will allow not only to identify individuals at risk of developing pathology but also to evaluate the effectiveness of therapeutic, preventive, and rehabilitation measures.\u0000Keywords: functional age; cardiorespiratory system","PeriodicalId":395284,"journal":{"name":"Issue 2 2022","volume":"5 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-05-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114794370","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Posttraumatic stress disorder: online poll of people who experienced war stress in Ukraine in 2022 创伤后应激障碍:对2022年乌克兰经历战争压力的人进行的在线调查
Issue 2 2022 Pub Date : 2022-05-03 DOI: 10.47855/jal9020-2022-2-4
A. Pisaruk, V. Shatilo, V.Р. Chyzhova, N. Koshel, L. Pisaruk, S. Ivanov
{"title":"Posttraumatic stress disorder: online poll of people who experienced war stress in Ukraine in 2022","authors":"A. Pisaruk, V. Shatilo, V.Р. Chyzhova, N. Koshel, L. Pisaruk, S. Ivanov","doi":"10.47855/jal9020-2022-2-4","DOIUrl":"https://doi.org/10.47855/jal9020-2022-2-4","url":null,"abstract":"Abstract. The gold standard for diagnosing PTSD is structured clinical interviews, the PCL-5 scale. To use of this English-language translator in Ukraine, we have made a translation to the Ukrainian language. For the collection of data, we use the online method which was divided by the Google company (Google Forms). Our task was to measure the frequency of PTSD development in different groups of people who survived the military stress in Ukraine from February -to April of 2022. The interview was taken with 212 persons years of aged 18 to 82 years, which live in Kyiv and before the city. The experiment was carried out from April 14 to May 17, 2022. The incidence of PTSD in people who were in the war zone was 43.1%, and in refugees - 27.5%. At the same time, in people who were outside the combat zone, the incidence of PTSD was significantly lower - 18.6%. Thus, the verification of the PCL-5 scale on the Ukrainian population of people affected by the war showed that this scale adequately assesses the severity of war stress and can be used for diagnostic PTSD.\u0000Keywords: war stress, posttraumatic stress disorder, Ukraine-2022","PeriodicalId":395284,"journal":{"name":"Issue 2 2022","volume":"53 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-05-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"133869278","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Quercetin effect on endogenous factors of cardiovascular risk and ageing biomarkers in elderly people 槲皮素对老年人心血管危险内源性因素和衰老生物标志物的影响
Issue 2 2022 Pub Date : 2022-05-02 DOI: 10.47855/10.47855/jal9020-2022-2-1
V. Shatilo, I. Antonyuk-Shcheglova, S. Naskalova, O. Bondarenko, Oksana Hrib, Dmitry Krasnienkov, A. Pisaruk
{"title":"Quercetin effect on endogenous factors of cardiovascular risk and ageing biomarkers in elderly people","authors":"V. Shatilo, I. Antonyuk-Shcheglova, S. Naskalova, O. Bondarenko, Oksana Hrib, Dmitry Krasnienkov, A. Pisaruk","doi":"10.47855/10.47855/jal9020-2022-2-1","DOIUrl":"https://doi.org/10.47855/10.47855/jal9020-2022-2-1","url":null,"abstract":"Abstract. The reason for this study was the lack of literature data on the quercetin effect on endogenous cardiovascular risk factors and ageing biomarkers in elderly patients with metabolic syndrome (MS). The results of this study showed that quercetin has a favourable corrective effect on endogenous cardiovascular risk factors in elderly patients with MS, quercetin course increases the resistance of the elderly to the effects of hypoxia, long-term quercetin use (within 3 months) leads to lengthening of telomeres and a decrease in metabolic age, which indicates the presence of a geroprotective effect. The obtained results of the quercetin course application influence on the telomere length show the expediency of continuing the study of this drug as an effective geroprotective agent.\u0000Keywords: quercetin; metabolic syndrome; endogenous factors; ageing biomarkers; geroprotective effect","PeriodicalId":395284,"journal":{"name":"Issue 2 2022","volume":"56 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-05-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"132361067","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信